Istaroxime has previously completed two positive Phase 2 studies in SCAI Stage B cardiogenic shock; the SEISMiC C study in SCAI Stage C cardiogenic shock is another step progressing to the istaroxime ...

Current guidelines support culprit-only PCI in these cases, but the “hypothesis-generating” results suggest taking a closer ...

Doctors at the City International Hospital (CIH) have successfully saved the life of a 43-year-old man in HCM City who ...

Cardiogenic shock is a medically urgent condition and drug treatment innovation is desired by providers who treat the conditionWARRINGTON, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, ...

If you’ve lived any amount of time on this earth, you’ve probably experienced a broken heart of some kind. Whether you got ...

A newly published study in the Journal of the American Heart Association found that men are more likely to die from the ...

Among patients with cardiogenic shock, vasopressin administration in the first 24 hours was linked to lower in-hospital ...

Broken heart syndrome is especially hard on men, even though the study found that 83% of people who develop the disorder are ...

The following is a summary of “Cardiogenic shock in systemic sclerosis: a retrospective study of acute ventricular ...

If istaroxime is granted the new chemical entity designation from FDA, it could provide 7.5 years of U.S. exclusivity and additionally the istaroxime U.S. issued method of use patent protects until ...

yet cardiac surgeons are not particularly willing to operate in the acute MI setting. In terms of left main disease, the very first patient described with cardiogenic shock was by Herrick in 1912 ...

Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have shown that increasing survival rates in cardiogenic shock is challenging.